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HYPOTHYROIDISM IN CONGENITAL RUBELLA
SIR,&mdash;Several manifestations of intrauterine rubella may
develop months or years after birth. This late-onset disease
may be due to direct action of the persisting infection or to an
immunopathological process.’ 1
A small-for-dates girl was born by spontaneous breech at 40
weeks menstrual age in May, 1972. Birthweight 2.0 kg and
occiputofrontal circumference 30 cm. Rubella-antibody titre
was 1/256, but there were no signs of congenital rubella. At
age 2 years she was still small but bone age was normal. Over
the next year her growth velocity slowed further and she was
admitted for investigation. Her height was 80.4 cm and weight
8.2 kg, both below the third centile. Her skin was dry and sca-
ly ; there was no goitre. Fundoscopy showed evidence of rubella
retinopathy.
Thyroxine 37 mmol/1 (normal 59-138); serum thyroid-sti-
mulating hormone >64 &micro;U/ml (normal 10-35); thyroglobu-
lin (tanned-red-cell) titre 1/2560; thyroid microsomal
heemagglutination-titre 160;2 rubella antibody 1/320 (aged 3
years 11 months); bone age 2 years 2 months (chronological
age 3 years 4 months). She became biochemically euthyroid
(T.S.H.<1.0 &micro;U/ml) on L-thyroxine 0.05 mg three times daily.
Her height has increased by 9.4 cm in 10 months.
The very rare association of poor intrauterine growth and
juvenile hypothyroidism in this patient has been emphasised at
a recent clinical meeting of the Royal Society of Medicine,
Pxdiatric Section. Two recent reports2 3 from overseas of
the association between hypothyroidism and congenital rubella
have prompted this letter. The raised thyroid-antibody titres
showed evidence of a thyroiditis caused by continuing rubella
infection acquired in utero. Cooper reported a case of hypo-
thyroidism in congenital rubella and one other case in the
United Kingdom is known.5
If growth and development are slower than expected in
children with congenital rubella, thyroid function should be
assessed, but in such a clinical state other endocrine disorders
may be responsible, such as growth-hormone deficiency.6
I thank Dr W. C. Marshall for his encouragement and advice in
writing this report, and Dr David Harvey for his permission.
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FATAL INHALATION OF
METHYLFLUOROSULPHATE
SIR,&mdash;Methylfluorosulphate (CH3OS02F) is used in many
laboratories as a methylating agent. A fatal accident in the
department of chemical technology at this university high-
lights the hazard of inhaling only a minute quantity of this
very toxic substance.
On March 25, 1976, at 11.30 A.M. a 25-year-old chemist
spilt a few millilitres of a fluid containing methylfluorosul-
phate on his laboratory coat and pullover. He immediately
took off the coat and cleaned his pullover with water. Although
he had no complaints, the man was sent to hospital at about
1 P.M. No abnormality was found, and he was allowed to go
home. At 5 P.M. the man began to cough a little and had some
difficulty with deep breathing. At 7 P.M. he was admitted to
hospital in a moribund state due to pulmonary cedema. He
died the next day despite intensive treatment.
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Protein denaturation seems to be the major contributor to
the development of pulmonary oedema. Moreover, hydrogen
fluoride and sulphuric acid are generated when methylfluoro-
sulphate makes contact with water.
This case should be a serious warning to everyone working
with methylfluorosulphate. Immediate administration of corti-
costeroids should be considered if this or other alkylating
agents is thought to have been inhaled. Continuous close
observation during the first 24 h is necessary.
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ASCORBIC ACID AND PARAQUAT TOXICITY
SIR,&mdash;Paraquat is extremely toxic, and even the most
vigorous treatments may not be able to prevent death after
exposure to the chemical.’ Paraquat toxicity seems to be due
to the ability of the reduced form of this compound to generate
the superoxide radical,2-4 which can undergo several reactions
leading to lipid peroxidation and tissue damage. The enzyme
superoxide dismutase catalyses the breakdown of the superox-
ide radical,s and attempts have been made to use this enzyme
to treat paraquat-poisoned animals. Promising results in pre-
liminary experiments6 have not been confirmed, and the lack
of effect of superoxide dismutase seems to be due to its inability
to penetrate cells.’ What is therefore required is a compound,
transported into lung tissue, which can react with superoxide,
Such a compound is ascorbic acid. 9 It enters the lung from
the blood and appears to accumulate in the fluid lining the air
spaces, and its reaction with superoxide has been directly
demonstrated.9 The toxicity of hyperbaric oxygen seems to be
due to increased formation of superoxide, 10 and in rats exposed
to hyperbaric oxygen prior administration of ascorbic acid les-
sened the toxic effects. 11
Since massive doses of ascorbic acid do not seem signifi-
cantly harmful to man,12 it might be possible to use this treat-
ment in paraquat poisoning.
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BLAST-CELL TRANSFORMATION CHRONIC
GRANULOCYTIC LEUK&AElig;MIA
SIR,&mdash;Howes and Emerson" described a patient having blas-
tic crisis in chronic granulocytic leukaemia with features sug-
gesting lymphoblastic rather than myeloblastic transfoma-
tion.
We have seen a 38-year-old man who was admitted after a
fall which caused a massive hasmatoma of his leg without bone
injury. Hb 6.8 g/dl, white-cell count 200 x 109/1 with granuto-
cytes at all stages of maturation, and platelets 800 x 109/l.
The neutrophil alkaline-phosphatase score was 7 and Philadel-
phia chromosome was demonstrated in the peripheral blood,
The spleen was enlarged.
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